Because the clinical outcome of NPC patients with a high HK2 expression level is worse than that of those with a low level of HK2 expression, depleting HK2 from NPC cells might improve the outcome of radiation-based treatment. Here, HK2 is linked to nasopharyngeal carcinoma.